Erratum for Committee on Drugs, Pediatrics 101 (6) 1079-1088.
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 102 No. 3 September 1998, p. 660

ERRATUM

In the policy statement entitled "Neonatal Drug Withdrawal" (June 1998;101:1079-1088), an incorrect dosage for clonidine was inadvertently published. On page 1084, under the heading "Clonidine," line 9, the sentence should read as follows:

"In an open trial, six of seven infants with neonatal narcotic withdrawal signs were treated effectively with oral clonidine (0.5 to 1.0 µg/kg [not mg/kg] in a single dose, followed by a maintenance dose of 3 to 5 µg/kg/day [not mg/kg/day], divided every 4 to 6 hours).83"

As stated in this AAP policy statement in reference to the treatment for neonatal drug withdrawal: "Larger controlled trials and pharmacokinetic data are needed before clonidine can be advocated as routine treatment."

We regret any confusion this error has caused.

Owing to concerns regarding patient safety, the electronic version of the article has been altered to reflect the correct dose.


Pediatrics (ISSN 0031 4005). Copyright ©1998 by the American Academy of Pediatrics

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JAMAHome page
E. L. Moses-Kolko, D. Bogen, J. Perel, A. Bregar, K. Uhl, B. Levin, and K. L. Wisner
Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors: Literature Review and Implications for Clinical Applications
JAMA, May 18, 2005; 293(19): 2372 - 2383.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?